Advertisement
Life-Sciences-Asia.com
The Asian Life Sciences Web Portal
This is a free web portal for the life sciences in Asia... » read more
- AC Immune & Takeda: up to $2.2b for Alzheimer Drug Candidate (2024-05-13)
- Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression - AC Immune to receive upfront payment of $100 million upon closing and be el... - Memo Therapeutics Increases Series C by CHF20m to CHF45m (2024-05-07)
> Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing investors > Proceeds will be used to expand Phase II of best-in-class anti-BK Virus antibody to become the largest study ever conducted for BK virus i... - Latus Bio Launches with $54m in Series A Financing 1st Close (2024-05-02)
Series A financing co-led by 8VC and DCVC Bio Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in ... - PeptiDream & Novartis Expand Peptide Discovery Collaboration (2024-04-30)
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo: 4587) today announced an expansion of its peptide discovery collaboration with Swiss-based Novartis Pharma AG (“he... - Miltenyi Biotec and MiLaboratories: Strategic Partnership (2024-04-29)
Miltenyi Biotec, a global pioneer in biotechnology, and MiLaboratories, a leader in RNA immune technologies are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies. This collaboration combines MiLaborator... - Smart Reporting Closes €23m Series C Led by TVM Capital (2024-04-22)
> TVM Capital Life Science and Bayern Kapital are new investors in the Munich-based healthtech company > Among other things, the capital will be used to further strengthen the company's presence in North America and Australia > Technology leadership to be exp... - Theolytics Closes £19m Financing Round (2024-04-17)
> Sound Bioventures joins strong international syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises and The University of Oxford. > New funding enables Theolytics to advance lead candidate THEO-260 through to clinical pro... - KBI Biopharma Appoints Jean-Baptiste Agnus as CBO (2024-04-15)
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team. JB bring... - Naobios and Sumagen Partner to Develop HIV Vaccine (2024-04-15)
Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of viru... - Nanoform: Exlusive Partnership with CBC Co. Ltd. in Japan (2024-04-11)
Nanoform Finland Plc (“Nanoform”) today announced a strategic partnership whereby CBC Co., Ltd. (“CBC”), will utilize its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoform’s cutting-edge nanomedicine engin...
Life-Sciences-Asia.com is your doorway to the Asian life sciences!
[LSA] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Asian region.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top